Insider Transactions in Q1 2021 at Alimera Sciences Inc (ALIM)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 09
2021
|
John Philip Jones Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,164
-5.73%
|
$8,148
$7.64 P/Share
|
|
Mar 08
2021
|
David Holland Chief Marketing Officer & SVP |
SELL
Payment of exercise price or tax liability
|
Direct |
1,935
-7.15%
|
$13,545
$7.42 P/Share
|
|
Mar 04
2021
|
Philip Ashman President of Int'l Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,533
-11.54%
|
$17,731
$7.77 P/Share
|
|
Jan 07
2021
|
David Holland Chief Marketing Officer & SVP |
BUY
Grant, award, or other acquisition
|
Direct |
5,625
+17.21%
|
-
|
|
Jan 07
2021
|
Samer Kaba Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+29.51%
|
-
|
|
Jan 07
2021
|
Philip Ashman President of Int'l Operations |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+31.29%
|
-
|
|
Jan 07
2021
|
John Philip Jones Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,625
+23.83%
|
-
|
|
Jan 07
2021
|
Richard S Eiswirth Jr President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+22.71%
|
-
|